Skip to content
Screener

Kodiak Sciences Inc KOD Operating Lease Liabilities

Operating Lease Liabilities at other companies

EyePoint, Inc. logo
EyePoint, Inc.EYPT
$19.81M-9.2%
KLR
Kalaris TherapeuticsKLRS
$1.09M
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$15.05M-17.2%
HRO
HarrowHROW
$7.67M-10.7%
PVL
Palvella TherapeuticsPVLA
$375K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$10.6M+24.9%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Accrued and other current liabilities26,56920,607
Operating lease liability11,66012,063
Total current liabilities49,57345,533
Long-term operating lease liability44,33247,117
Liability related to sale of future royalties100,000100,000
Long-term deposit1,500
Total liabilities193,905194,150
Commitments and contingencies (Note 5)

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's operating lease liabilities?
Kodiak Sciences Inc (KOD) reported operating lease liabilities of $44.33M in Q1 2026.
How has Kodiak Sciences Inc's operating lease liabilities changed year-over-year?
Kodiak Sciences Inc's operating lease liabilities decreased by 21.8% year-over-year, from $56.69M to $44.33M.
What is the long-term trend for Kodiak Sciences Inc's operating lease liabilities?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's operating lease liabilities has grown at a -8.9% compound annual growth rate (CAGR), from $75.03M to $47.12M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Ask your AI about Kodiak Sciences Inc's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude